Sinocare
Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing.
Launch date
Employees
Market cap
$2.1b
Enterprise valuation
$2.2b (Public information from Sep 2024)
Share price
CNY27.27 300298.SZ
Changsha Hunan (HQ)
Financials
Estimates*
CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 2.0b | 2.4b | 2.8b | 4.1b | 4.6b | 5.2b | 6.0b |
% growth | 13 % | 17 % | 19 % | 44 % | 14 % | 13 % | 14 % |
EBITDA | 506m | 390m | 639m | 655m | 757m | 895m | 1.0b |
% EBITDA margin | 25 % | 17 % | 23 % | 16 % | 16 % | 17 % | 17 % |
Profit | 187m | 108m | 431m | 284m | 432m | 528m | 646m |
% profit margin | 9 % | 5 % | 15 % | 7 % | 9 % | 10 % | 11 % |
EV / revenue | 9.9x | 7.1x | 6.7x | 4.2x | 2.9x | 2.6x | 2.3x |
EV / EBITDA | 39.6x | 43.1x | 29.4x | 25.8x | 17.9x | 15.2x | 13.0x |
R&D budget | 182m | 182m | 260m | 356m | - | - | - |
R&D % of revenue | 9 % | 8 % | 9 % | 9 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | N/A | Post IPO Equity | |
Total Funding | - |
Recent News about Sinocare
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.